Table 3.
Multivariable regression analysis of CA-AKI in different definition.
| Variables | CA-AKI 0350 | CA-AKI 0525 | ||
|---|---|---|---|---|
| OR (95% CI) | P-Value | OR (95% CI) | P-Value | |
| Dilated vs. normala | 1.31 (1.06–1.61) | 0.010 | 1.32 (1.04–1.67) | 0.020 |
| Age | 1.01 (1.01–1.01) | <0.001 | 1.02 (1.01–1.03) | <0.001 |
| Gender | 1.58 (1.33–1.88) | <0.001 | 1.23 (1.00–1.51) | 0.052 |
| AMI | 1.11 (0.94–1.32) | 0.205 | 0.81 (0.65–1.01) | 0.069 |
| HT | 1.01 (0.85–1.19) | 0.938 | 1.02 (0.83–1.25) | 0.869 |
| DM | 1.11 (0.94–1.32) | 0.205 | 1.21 (0.99–1.46) | 0.056 |
| Anemia | 1.36 (1.15–1.60) | <0.001 | 1.46 (1.21–1.77) | <0.001 |
| HFrEF | 1.53 (1.21–1.94) | <0.001 | 1.48 (1.19–1.83) | <0.001 |
| CKD | 2.40 (1.99–2.90) | <0.001 | 0.99 (0.84–1.17) | 0.926 |
| CMV>200 | 1.22 (0.99–1.50) | 0.063 | 1.43 (1.13–1.81) | 0.003 |
| Diuretics | 1.96 (1.65–2.34) | <0.001 | 1.84 (1.50–2.25) | <0.001 |
a: Dilated LVEDD compared with Normal LVEDD1.
CA-AKI0350: an absolute Scr increase ≥ 0.3 mg/dL or a relative increase in serum creatinine ≥ 50% within 48 h after contrast medium exposure.
CA-AKI0525: an absolute Scr increase ≥ 0.5 mg/dL or a relative increase in serum creatinine ≥ 25% within 72 h after contrast medium exposure.
LVEDD, left ventricular end-diastolic diameter; AMI, acute myocardial infarction; HT, hypertension; DM, diabetes mellitus; HFrEF, Heart failure with reduced ejection fraction; CKD, chronic kidney disease; CMV, contrast medium volume.